JOHNSON & JOHNSON (JNJ)
Clinical trial NCT07784387 updates: 1. start date: 2026-08-31 → 2026-08-25 2. completion date: 2028-02-29 → 2028-02-25
NORTHWEST BIOTHERAPEUTICS INC
Clinical trial NCT05185180 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-11 → 2023-03-07 3. primary completion date: 2025-06-01 → 2023-03-07 4. enrollment: 50 → 11 participants 5. enrollment type: ESTIMATED → ACTUAL
JOHNSON & JOHNSON (JNJ)
Clinical trial NCT05299125 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-07-31 → 2025-11-21 3. primary completion date: 2026-01-30 → 2024-08-19
NOVO NORDISK A S (NVO)
Clinical trial NCT07607600 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 100 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL
JOHNSON & JOHNSON (JNJ)
Clinical trial NCT06116786 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 126 → 67 participants 3. enrollment type: ESTIMATED → ACTUAL
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT05986864 updates: 1. completion date: 2026-01-30 → 2027-01-30 2. primary completion date: 2026-01-01 → 2027-01-01
PFIZER INC (PFE)
Clinical trial NCT03375242 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-11-06 → 2026-08-10 3. primary completion date: 2026-11-06 → 2026-08-10
REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07543055 updates: 1. start date: 2026-08-10 → 2026-09-10 2. completion date: 2031-04-25 → 2031-06-27 3. primary completion date: 2030-02-05 → 2030-02-02
ROCHE HOLDING LTD (RHHBF)
Clinical trial NCT06068985 updates: 1. completion date: 2032-04-01 → 2032-11-01 2. primary completion date: 2026-04-01 → 2027-04-01
BEONE MEDICINES LTD. (ONC)
Clinical trial NCT04170283 updates: 1. completion date: 2028-12-01 → 2026-12-31 2. primary completion date: 2027-11-01 → 2026-12-31
BANK OF NOVA SCOTIA (BNS)
MERCK & CO., INC. (MRK)
Clinical trial NCT05298423 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-19 → 2026-06-15 3. enrollment: 611 → 610 participants
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT07429942: start date: 2026-08-31 → 2026-09-10.
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT04090710 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-06-30 3. primary completion date: 2026-06-30 → 2026-04-23
JOHNSON & JOHNSON (JNJ)
Clinical trial NCT06785012: status: ACTIVE_NOT_RECRUITING → COMPLETED.